Valuation: Beijing Science Sun Pharmaceutical Co., Ltd.

Market Cap	4.64B 687M 595M 555M 509M 958M 65.41B 973M 6.51B 2.56B 32.79B 2.58B 2.52B 108B	P/E 2024	-50.1x	P/E 2025	353x
Enterprise Value	3.1B 459M 397M 371M 340M 639M 43.66B 650M 4.35B 1.71B 21.89B 1.72B 1.69B 72.35B	EV / Sales 2024	4.33x	EV / Sales 2025	8.78x
Free-Float	42.82%	Yield 2024 *	-	Yield 2025	2.84%

* Estimated data More valuation ratios

Chart: Beijing Science Sun Pharmaceutical Co., Ltd.

Dynamic Chart

Latest news : Beijing Science Sun Pharmaceutical Co., Ltd.

07-28	Beijing Science Sun Pharmaceutical Gets China Approval for Blood Sugar Lowering Tablets	MT
04-28	Beijing Science Sun Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
04-24	India stocks, rupee, swaps, call at 3:30 p.m. IST	RE
04-08	Science Sun Pharma's Subsidiary Secures 5-Year Production License Renewal; Shares Down 3%	MT
03-31	Beijing Science Sun Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2025	CI
03-30	Beijing Science Sun Pharmaceutical Co., Ltd. announces Annual dividend, payable on May 27, 2026	CI
23/10/25	Beijing Science Sun Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2025	CI
19/09/25	Science Sun Pharmaceutical's shareholders to unload stake in co	RE
21/08/25	Beijing Science Sun Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2025	CI
23/07/25	Beijing Science Sun Pharmaceutical Gets Approval for Site Relocation; Shares Down 4%	MT
20/06/25	Beijing Science Sun Subsidiary to Transfer Protein Production Project for 20 Million Yuan	MT
23/04/25	Beijing Science Sun Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2025	CI
28/03/25	Beijing Science Sun Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2024	CI

More news

Managers and Directors: Beijing Science Sun Pharmaceutical Co., Ltd.

Manager	Title	Age	Since
Biao Ma CEO	Chief Executive Officer	62	05/07/2001
Dong Na Liang DFI	Director of Finance/CFO	45	26/01/2024
Li Ma DFI	Director of Finance/CFO	57	15/12/2006

Director	Title	Age	Since
Xue Feng Wang BRD	Director/Board Member	48	01/03/2009
Biao Ma CHM	Chairman	62	05/07/2001
Li Ma BRD	Director/Board Member	57	01/10/2005

More insiders

Beijing Science Sun Pharmaceutical Co Ltd is a China-based company mainly engaged in the research and development, production and sales of injectables. The Company's products are biological and biochemical drugs, covering several drug use areas: cardiovascular and cerebrovascular diseases, immune diseases (anti-tumor) and nervous system diseases. The main products of immunomodulatory drugs are Saisheng Bozhi glycopeptide injection and Saisheng deoxyribonucleotide sodium injection. The main products of cardiovascular and cerebrovascular drugs are Saibai fibrinolytic enzyme injection, myo-aminopeptide injection and myo-aminopeptide injection. The main product of nervous system drugs is Saidian monosialotetrahexosylganglioside sodium injection (GM-1). The Company mainly conducts its businesses in the domestic market.

Employees

489

Sector

Pharmaceuticals

Calendar

08-24 Earnings release - Q2 2026

More about the company

Quotes

Date	Price	Change	Volume
07/08/26	CN¥9.630	+5.94%	14,322,730
06/08/26	CN¥9.090	-0.66%	5,094,300
05/08/26	CN¥9.150	+0.11%	5,462,205
04/08/26	CN¥9.140	+2.70%	7,066,002
03/08/26	CN¥8.900	+1.14%	4,687,800

End-of-day quote Shenzhen S.E.

More quotes

Income Statement and Estimates

More financial data

Select your edition

All financial news and data tailored to specific country editions

NORTH AMERICA

United-States

Canada

End-of-day quote Shenzhen S.E. Other stock markets 07/08/2026			5-day change	1st Jan Change
9.630 ^CNY	+5.94%		+9.43%	-8.98%

1 day	+5.94%
1 week	+9.43%
Current month	+9.43%
1 month	+3.88%
3 months	-10.67%
6 months	-15.15%
Current year	-8.98%

1 week	8.73	9.65
1 month	8.35	10.51
Current year	7.77	12.9
1 year	7.77	16.25
3 years	5.73	17.49
5 years	5.73	18.75
10 years	5.73	28.08

Date	Insider	Type	Main position	Quantity	% Market Cap.
20/01/26	Li Ma	Sell	Director	780,000	0.3078%
15/01/26	Li Ma	Sell	Director	2,301,800	0.9083%
14/01/26	Li Ma	Sell	Director	820,000	0.3236%

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
BEIJING SCIENCE SUN PHARMACEUTICAL CO., LTD.	+5.94%	+9.43%	-33.77%	-8.11%	687M
ELI LILLY AND COMPANY	-0.52%	+3.21%	+85.02%	+161.12%	1,057B
JOHNSON & JOHNSON	+0.88%	+1.13%	+51.13%	+49.76%	625B
ABBVIE INC.	+0.89%	-1.95%	+23.73%	+63.67%	435B
ROCHE HOLDING AG	+0.71%	+3.87%	+47.45%	+38.68%	363B
NOVARTIS AG	+0.64%	-0.49%	+35.39%	+40.21%	296B
ASTRAZENECA PLC	+0.39%	-5.83%	+8.64%	+9.28%	249B
AMGEN INC.	+1.51%	+6.69%	+44.34%	+62.47%	222B
NOVO NORDISK A/S	+3.92%	-0.46%	-1.21%	-44.09%	209B
GILEAD SCIENCES, INC.	+1.80%	+2.30%	+20.79%	+65.13%	165B
Average	+1.78%	+1.60%	+28.15%	+43.81%	362.15B
Weighted average by Cap.	+1.12%	+1.22%	+48.32%	+75.32%

Beijing Science Sun Pharmaceutical Co., Ltd. Stock

Stocks

300485

CNE100002110

Pharmaceuticals

Valuation: Beijing Science Sun Pharmaceutical Co., Ltd.

Chart: Beijing Science Sun Pharmaceutical Co., Ltd.

Latest news : Beijing Science Sun Pharmaceutical Co., Ltd.

Quotes and Performance

Course Extremes

Managers and Directors: Beijing Science Sun Pharmaceutical Co., Ltd.

Latest insider transactions

Other Pharmaceuticals

Financials

Company Profile

Quotes

Income Statement and Estimates

	2024	2025
Net sales	416M 61.71M 53.38M 49.85M 45.73M 86.01M 5.87B 87.38M 585M 230M 2.94B 232M 227M 9.73B	405M 59.97M 51.87M 48.44M 44.44M 83.58M 5.71B 84.91M 568M 223M 2.86B 225M 220M 9.46B
Net income	-68.85M -10.2M -8.83M -8.24M -7.56M -14.22M -971M -14.45M -96.69M -37.95M -487M -38.31M -37.47M -1.61B	14.57M 2.16M 1.87M 1.74M 1.6M 3.01M 205M 3.06M 20.46M 8.03M 103M 8.11M 7.93M 340M
Net Debt	-1.57B -233M -201M -188M -173M -325M -22.16B -330M -2.21B -866M -11.11B -875M -855M -36.73B	-1.54B -229M -198M -185M -169M -318M -21.75B -324M -2.17B -850M -10.9B -858M -839M -36.04B